135 related articles for article (PubMed ID: 34012027)
1. Integrated analysis of miRNA-mRNA interaction in pediatric dilated cardiomyopathy.
Hailu FT; Karimpour-Fard A; Toni LS; Bristow MR; Miyamoto SD; Stauffer BL; Sucharov CC
Pediatr Res; 2022 Jul; 92(1):98-108. PubMed ID: 34012027
[TBL] [Abstract][Full Text] [Related]
2. Circulating and Cardiac Tissue miRNAs in Children with Dilated Cardiomyopathy.
Hailu FT; Karimpour-Fard A; Neltner B; Stauffer BL; Lipshultz S; Miyamoto SD; Sucharov CC
J Cardiovasc Dev Dis; 2023 Sep; 10(9):. PubMed ID: 37754820
[TBL] [Abstract][Full Text] [Related]
3. Integrated Analysis of Hub Genes and miRNAs in Dilated Cardiomyopathy.
Huang K; Wen S; Huang J; Wang F; Pang L; Wang Y; Sun X
Biomed Res Int; 2020; 2020():8925420. PubMed ID: 33015184
[TBL] [Abstract][Full Text] [Related]
4. Integrated regulatory network based on lncRNA-miRNA-mRNA-TF reveals key genes and sub-networks associated with dilated cardiomyopathy.
Charles S; Natarajan J
Comput Biol Chem; 2021 Jun; 92():107500. PubMed ID: 33940530
[TBL] [Abstract][Full Text] [Related]
5. Small RNA-sequencing identified the potential roles of neuron differentiation and MAPK signaling pathway in dilated cardiomyopathy.
Huang G; Cao M; Huang Z; Xiang Y; Liu J; Wang Y; Wang J; Yang W
Biomed Pharmacother; 2019 Jun; 114():108826. PubMed ID: 30948207
[TBL] [Abstract][Full Text] [Related]
6. Detection and comparison of microRNA expression in the serum of Doberman Pinschers with dilated cardiomyopathy and healthy controls.
Steudemann C; Bauersachs S; Weber K; Wess G
BMC Vet Res; 2013 Jan; 9():12. PubMed ID: 23327631
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathy.
Miyamoto SD; Karimpour-Fard A; Peterson V; Auerbach SR; Stenmark KR; Stauffer BL; Sucharov CC
J Heart Lung Transplant; 2015 May; 34(5):724-33. PubMed ID: 25840506
[TBL] [Abstract][Full Text] [Related]
8. Sexual dimorphisms of mRNA and miRNA in human/murine heart disease.
Tsuji M; Kawasaki T; Matsuda T; Arai T; Gojo S; Takeuchi JK
PLoS One; 2017; 12(7):e0177988. PubMed ID: 28704447
[TBL] [Abstract][Full Text] [Related]
9. Circulating cardiac MicroRNAs safeguard against dilated cardiomyopathy.
Cheng X; Jian D; Xing J; Liu C; Liu Y; Cui C; Li Z; Wang S; Li R; Ma X; Wang Y; Gu X; Ge Z; Tang H; Liu L
Clin Transl Med; 2023 May; 13(5):e1258. PubMed ID: 37138538
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.
Bernardo BC; Ooi JY; Matsumoto A; Tham YK; Singla S; Kiriazis H; Patterson NL; Sadoshima J; Obad S; Lin RC; McMullen JR
J Physiol; 2016 Oct; 594(20):5959-5974. PubMed ID: 27270487
[TBL] [Abstract][Full Text] [Related]
11. Meta-Analysis of Dilated Cardiomyopathy Using Cardiac RNA-Seq Transcriptomic Datasets.
Alimadadi A; Munroe PB; Joe B; Cheng X
Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31948008
[TBL] [Abstract][Full Text] [Related]
12. Genomic analysis of circular RNAs in heart.
Dong K; He X; Su H; Fulton DJR; Zhou J
BMC Med Genomics; 2020 Nov; 13(1):167. PubMed ID: 33160353
[TBL] [Abstract][Full Text] [Related]
13. MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM.
Li M; Chen X; Chen L; Chen K; Zhou J; Song J
J Transl Med; 2018 Jun; 16(1):161. PubMed ID: 29885652
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs as novel biomarkers for dilated cardiomyopathy.
Wang H; Chen F; Tong J; Li Y; Cai J; Wang Y; Li P; Hao Y; Tian W; Lv Y; Chong J; Yang J
Cardiol J; 2017; 24(1):65-73. PubMed ID: 27748501
[TBL] [Abstract][Full Text] [Related]
15. The integrated analysis of RNA-seq and microRNA-seq depicts miRNA-mRNA networks involved in Japanese flounder (Paralichthys olivaceus) albinism.
Wang N; Wang R; Wang R; Tian Y; Shao C; Jia X; Chen S
PLoS One; 2017; 12(8):e0181761. PubMed ID: 28777813
[TBL] [Abstract][Full Text] [Related]
16. RNA sequencing discloses the genome‑wide profile of long noncoding RNAs in dilated cardiomyopathy.
Huang G; Liu J; Yang C; Xiang Y; Wang Y; Wang J; Cao M; Yang W
Mol Med Rep; 2019 Apr; 19(4):2569-2580. PubMed ID: 30720098
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure.
Sweet ME; Cocciolo A; Slavov D; Jones KL; Sweet JR; Graw SL; Reece TB; Ambardekar AV; Bristow MR; Mestroni L; Taylor MRG
BMC Genomics; 2018 Nov; 19(1):812. PubMed ID: 30419824
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome signature of ventricular arrhythmia in dilated cardiomyopathy reveals increased fibrosis and activated TP53.
Haywood ME; Cocciolo A; Porter KF; Dobrinskikh E; Slavov D; Graw SL; Reece TB; Ambardekar AV; Bristow MR; Mestroni L; Taylor MRG
J Mol Cell Cardiol; 2020 Feb; 139():124-134. PubMed ID: 31958463
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
20. Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy.
Toro R; Blasco-Turrión S; Morales-Ponce FJ; Gonzalez P; Martínez-Camblor P; López-Granados A; Brugada R; Campuzano O; Pérez-Serra A; Rosa Longobardo F; Mangas A; Llorente-Cortes V; de Gonzalo-Calvo D
J Mol Med (Berl); 2018 Aug; 96(8):845-856. PubMed ID: 30008018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
